BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 12352675)

  • 1. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.
    Berenholz L; Katzenell U; Harell M
    Laryngoscope; 2002 Sep; 112(9):1619-22. PubMed ID: 12352675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
    Bernstein JM; Holland NJ; Porter GC; Maw AR
    J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant otitis externa: case series.
    Ali T; Meade K; Anari S; ElBadawey MR; Zammit-Maempel I
    J Laryngol Otol; 2010 Aug; 124(8):846-51. PubMed ID: 20388240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Otitis externa maligna. Report of a case resistant to ciprofloxacin].
    Kindelan JM; Jurado R; No-Louis E; López-Villarejo P
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):657. PubMed ID: 1822159
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
    Levenson MJ; Parisier SC; Dolitsky J; Bindra G
    Laryngoscope; 1991 Aug; 101(8):821-4. PubMed ID: 1865729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant otitis externa in AIDS patients: case report and review of the literature.
    Weinroth SE; Schessel D; Tuazon CU
    Ear Nose Throat J; 1994 Oct; 73(10):772-4, 777-8. PubMed ID: 7805599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant or necrotizing otitis externa: experience in 22 cases].
    Martel J; Duclos JY; Darrouzet V; Guyot M; Bébéar JP
    Ann Otolaryngol Chir Cervicofac; 2000 Nov; 117(5):291. PubMed ID: 11084403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of gallium-67 in the assessment of response to antibiotic therapy in malignant otitis externa--a case report.
    Paramsothy M; Khanijow V; Ong TO
    Singapore Med J; 1997 Aug; 38(8):347-9. PubMed ID: 9364890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis and treatments of necrotizing otitis externa: a report of 19 cases.
    Chen YA; Chan KC; Chen CK; Wu CM
    Auris Nasus Larynx; 2011 Dec; 38(6):666-70. PubMed ID: 21353408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrotizing external otitis: a report of 46 cases.
    Franco-Vidal V; Blanchet H; Bebear C; Dutronc H; Darrouzet V
    Otol Neurotol; 2007 Sep; 28(6):771-3. PubMed ID: 17721365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic criteria and therapy of malignant external otitis].
    Crovetto de la Torre MA; Fiz Melsio L; Grande Icaran D
    Acta Otorrinolaringol Esp; 1996; 47(3):175-80. PubMed ID: 8924279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin for the treatment of chronic ear disease.
    Piccirillo JF; Parnes SM
    Laryngoscope; 1989 May; 99(5):510-3. PubMed ID: 2651829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas and acute external otitis. Results of a microbiological study in patients without previous antibiotic treatment].
    Pino Rivero V; Pantoja Hernández CG; González Palomino G; Mora Santos ME; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2007; 34(1):45-51. PubMed ID: 17405458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors.
    Loh S; Loh WS
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):991-6. PubMed ID: 23558287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant otitis externa in a younger diabetes patient.
    Gallen IW; Molitch ME
    Diabetes Care; 1992 Nov; 15(11):1826. PubMed ID: 1468326
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
    Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD; Kelbick NT
    Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and spectrum of bacterial isolates in infectious otitis externa.
    Arshad M; Khan NU; Ali N; Afridi NM
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):146-9. PubMed ID: 15228846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology of otitis externa in the secondary care in United Kingdom and antimicrobial sensitivity.
    Ninkovic G; Dullo V; Saunders NC
    Auris Nasus Larynx; 2008 Dec; 35(4):480-4. PubMed ID: 18314283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial otitis externa with invasion of organ limits--systemic and local combination treatment with ciprofloxacin].
    Ganz H
    Z Arztl Fortbild (Jena); 1993 Apr; 87(5):413-5. PubMed ID: 8322469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.